Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CCR2 | P41597 | 3/20 | 0.43 |
| ▸ | CCR3 | P51677 | 1/20 | 0.43 |
| ▸ | CPB1 | P15086 | 2/20 | 0.43 |
| ▸ | KDM1A | O60341 | 1/20 | 0.43 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | PREP | P48147 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5029150 | 1.00 | ALDH1A1 (0.55) | ALDH1A1GAATSHRMAPK1MEN1 | |
| SCHEMBL5027255 | 0.89 | ALDH1A1 (0.52) | ALDH1A1GAATSHRMAPK1MEN1 | |
| SCHEMBL5027250 | 0.89 | ALDH1A1 (0.52) | ALDH1A1GAATSHRMAPK1MEN1 | |
| SCHEMBL5027258 | 0.89 | ALDH1A1 (0.52) | ALDH1A1GAATSHRMAPK1MEN1 | |
| SCHEMBL5229279 | 0.79 | ALDH1A1 (0.60) | ALDH1A1GAATSHRMAPK1MEN1 | |
| SCHEMBL5027168 | 0.78 | ALDH1A1 (0.50) | ALDH1A1GAATSHRMEN1KMT2A | |
| SCHEMBL5029664 | 0.78 | ALDH1A1 (0.46) | ALDH1A1TSHRCCR2CCR3CPB1 | |
| SCHEMBL5027125 | 0.78 | ALDH1A1 (0.52) | ALDH1A1GAATSHRKMT2ACCR2 | |
| SCHEMBL3733860 | 0.78 | ALDH1A1 (0.52) | ALDH1A1GAATSHRKMT2ACCR2 | |
| SCHEMBL27667807 | 0.78 | ALDH1A1 (0.52) | ALDH1A1GAATSHRKMT2ACCR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7378409-B2 | Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-05-27 | — | — | US | disclosed |
| US-20050054626-A1 | Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY | 2005-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050054626-A1 | Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity | CCL11, CCR1, CCR2 | ALDH1A1 827/4885GAA 4005/4885TSHR 1726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.